載入中
NASDAQHealthcareMedical - Instruments & Supplies
最新資料
US$3.69
−US$0.316 · -7.89%
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
一般交易時段
US$3.69
−US$0.316 · -7.89%
盤中時間採用ET。市場資料可能有所延遲。
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
日內區間
目前US$3.69
52週區間
目前US$3.69
盤中時間採用ET。市場資料可能有所延遲。
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
日內區間
目前US$3.69
52週區間
目前US$3.69
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 1142.1萬 USD | 868.8萬 USD | 408.9萬 USD | 204.8萬 USD | 155.1萬 USD |
| 銷貨成本 | 691.2萬 USD | 594萬 USD | 371.5萬 USD | 179.2萬 USD | 154.3萬 USD |
| 毛利 | 450.9萬 USD | 274.8萬 USD | 37.4萬 USD | 25.6萬 USD | 8000 USD |
| 研究與開發 | 2000 USD | 7.8萬 USD | 10.3萬 USD | 36.7萬 USD | 3.1萬 USD |
| 銷售、一般及管理費用 | 785.9萬 USD | 591.1萬 USD | 339.8萬 USD | 281.6萬 USD | 240.5萬 USD |
| 營業費用 | 786.1萬 USD | 630.2萬 USD | 385.1萬 USD | 360.4萬 USD | 257.8萬 USD |
| 利息支出 | 3.4萬 USD | 8.1萬 USD | 1.5萬 USD | 133.6萬 USD | 199.8萬 USD |
| 折舊和攤銷 | 74萬 USD | 48萬 USD | 44.3萬 USD | 30.1萬 USD | 11.3萬 USD |
| 營業利益 | −335.2萬 USD | −355.4萬 USD | −347.7萬 USD | −334.8萬 USD | −257萬 USD |
| 淨利 | −300萬 USD | −328.1萬 USD | −315.7萬 USD | −474.6萬 USD | −431萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
